The aim of this prospective, nonrandomized clinical trial was to assess whether brimonidine 0.15% alters retinal vascular autoregulation and short-term visual function in 46 patients with ...

Major ophthalmic events in the first quarter of 2026 included treatments for presbyopia, age-related macular degeneration ...

- Galderma portfolio expands to offer a fast onset and long-acting alpha-2 adrenergic receptor agonist - Galderma, a leading global pharmaceutical company exclusively focused on dermatology, today ...

Please provide your email address to receive an email when new articles are posted on . Brimonidine preserved visual fields better than argon laser trabeculoplasty in a prospective clinical study in ...

Please provide your email address to receive an email when new articles are posted on . FLORENCE – Latanoprost and brimonidine were equally well tolerated and did not produce significant modifications ...

Learn everything you need to know about Brimonidine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...

Review the side-effects of Brimonidine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

The FDA approved carbachol/brimonidine tartrate ophthalmic solution (Yuvezzi) for adults with presbyopia, making it the first approved dual-agent eye drop therapy for age-related vision decline. The ...

Indication: Mirvaso ® (brimonidine) Topical Gel, 0.33%* is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of ...

In 2 short‑term randomised controlled trials (RCTs: n=553) brimonidine tartrate gel was statistically significantly more effective than vehicle gel in reducing erythema in people with a clinical ...

Whether NTG is entirely different from primary open-angle glaucoma (POAG), or whether it is simply on a continuum of the same disease process, is under debate. NTG is distinct from POAG in that ...